| scholarly article | Q13442814 |
| P2093 | author name string | Huang-Jen Chen | |
| Min-Shao Tsai | |||
| Shao-Hsing Weng | |||
| Ya-Hsun Kuo | |||
| Yu-Fan Chiu | |||
| Yun-Wei Lin | |||
| P2860 | cites work | A review of cancer chemopreventive agents | Q28189096 |
| Cancer statistics, 2006 | Q29615133 | ||
| Repair of DNA interstrand cross-links | Q34343361 | ||
| Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance | Q34536974 | ||
| Curcumin: getting back to the roots. | Q34563815 | ||
| Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. | Q34571928 | ||
| Curcumin and cancer: an "old-age" disease with an "age-old" solution | Q34776812 | ||
| The dual role of thymidine phosphorylase in cancer development and chemotherapy | Q34980526 | ||
| Chemoresistance in non-small cell lung cancer | Q36048311 | ||
| Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment | Q36057816 | ||
| Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC--a phase II trial | Q36610248 | ||
| Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Q37163664 | ||
| Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis | Q38283244 | ||
| The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells | Q38360146 | ||
| Curcumin reduced the side effects of mitomycin C by inhibiting GRP58-mediated DNA cross-linking in MCF-7 breast cancer xenografts | Q39809002 | ||
| Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells. | Q39866965 | ||
| Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation | Q39873493 | ||
| Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. | Q40078110 | ||
| Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. | Q40341471 | ||
| Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice | Q40358890 | ||
| Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells | Q40413196 | ||
| Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression | Q40418488 | ||
| Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway | Q40424818 | ||
| Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. | Q43804591 | ||
| Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. | Q44478685 | ||
| Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization | Q45182288 | ||
| Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. | Q46547397 | ||
| Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C. | Q46850345 | ||
| A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology | Q57569726 | ||
| P433 | issue | 3 | |
| P921 | main subject | cytotoxicity | Q246181 |
| curcumin | Q312266 | ||
| P304 | page(s) | 298-306 | |
| P577 | publication date | 2011-11-04 | |
| P1433 | published in | Basic and Clinical Pharmacology and Toxicology | Q15724438 |
| P1476 | title | Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression | |
| P478 | volume | 110 |
| Q38212780 | Curcumin and lung cancer--a review |
| Q38782479 | Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells |
| Q44774245 | Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy |
| Q38987177 | Inosine strongly enhances proliferation of human C32 melanoma cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways |
| Q39202165 | Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells. |
Search more.